Wrapped Bitcoin Falls More Than 4% In 24 hours

Wrapped Bitcoin's (CRYPTO: WBTC) price has decreased 4.65% over the past 24 hours to $65,664.00, continuing its downward trend over the past week of -6.0%, moving from $69,607.04 to its current price.

Wrapped Bitcoin’s (CRYPTO: WBTC) price has decreased 4.65% over the past 24 hours to $65,664.00, continuing its downward trend over the past week of -6.0%, moving from $69,607.04 to its current price.

The chart below compares the price movement and volatility for Wrapped Bitcoin over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.

price_chart

The trading volume for the coin has fallen 16.0% over the past week, moving in tandem, directionally, with the overall circulating supply of the coin, which has decreased 0.42%. This brings the circulating supply to 155 thousand, which makes up an estimated 100.0% of its max supply of 155 thousand. According to our data, the current market cap ranking for WBTC is #18 at $10.20 billion.

supply_and_vol

Powered by CoinGecko API

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

CHMP Issues Negative Opinion For Renewal Of Conditional Marketing Authorization For Translarna Following Re-Examination Procedure; Per European Regulations, The European Commission Has 67 Days To Adopt The Opinion

 PTC Therapeutics, Inc. (NASDAQ:PTCT) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a negative opinion following the re-examination

PTCT

Read More

Pharma Contract Service Provider Avid Bioservices Reports Negative Gross Margin In Q3, Issues Meek Outlook

Avid Bioservices Inc (NASDAQ: CDMO) reported Q2 FY24 sales of $25.4 million, down 27% Y/Y, primarily attributed to fewer year-to-date manufacturing runs, a reduction in process development services from early-stage customers, and a reduction of revenue for changes in estimated variable consideration un

CDMO